ISRG Intuitive Surgical NASDAQ pre-market 01 Apr 2026: $460.99 AI outlook

In pre-market trading on 01 Apr 2026, ISRG stock trades at $460.99, down from its 52-week high but supported by solid fundamentals and AI-driven robotics momentum. Intuitive Surgical, Inc. (ISRG) on NASDAQ posted EPS $7.88 and carries a PE 58.50, reflecting premium expectations for recurring system and consumable revenue. We examine valuation, technicals, and AI catalysts ahead of the April 21, 2026 earnings date and connect recent flows and analyst targets to short-term price risk.

ISRG stock: Key market data and recent moves

Intuitive Surgical, Inc. (ISRG) trades on NASDAQ in the United States with a market cap of $163.71 billion and volume 1,943,915 today. The share price range this session is $448.40–$463.00, year low $425.00 and year high $603.88. Institutional ownership remains high at 83.64%, while insiders sold 32,943 shares in the last 90 days, which has contributed to near-term supply pressure.

ISRG stock valuation and financials

Intuitive’s trailing twelve-month metrics show revenue per share $28.36, net income per share $8.05, and strong cash per share $16.72. The company carries a high multiple with PE 58.50 and price-to-sales around 16.32, signaling growth expectations. Analysts expect fiscal-year EPS near 6.43, while consensus price target sits near $614.95, implying material upside versus today’s price but also reflecting stretch valuation.

ISRG stock technicals and trading signals

Technical indicators point to short-term weakness: RSI 35.68 and MACD histogram negative at -1.66, with Bollinger middle at $478.42 and lower band $452.30. Average volume 1,951,700 suggests current volume is roughly in line with trend. Traders should watch the 50-day $493.85 and 200-day $507.15 moving averages for signs of trend reversion.

Meyka AI rates ISRG with a score out of 100

Meyka AI rates ISRG with a score of 79.66 out of 100, grade B+ and suggestion BUY. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The grade highlights strong cash generation, durable margins, and sector leadership, offset by a premium valuation that pressures near-term returns.

Meyka AI’s forecast model projects and analyst consensus

Meyka AI’s forecast model projects a yearly target $585.45 and a quarterly target $485.77, while the monthly near-term level is $438.35. Comparing the yearly figure to the current $460.99 implies an estimated upside of 27.00%. Forecasts are model-based projections and not guarantees. Wall Street consensus price target averages $614.95, with analyst mix: 16 buys, 4 holds, 2 sells contributing to a Moderate Buy profile.

AI catalysts, risks, and outlook for ISRG stock

Intuitive’s position as a pure-play surgical robotics leader ties directly to the AI stocks theme: digital surgical platforms, data-enabled performance insights, and the Ion diagnostic expansion offer AI-driven service and consumable growth. Key risks include valuation sensitivity, geopolitical-driven market sell-offs, and competition on pricing and training. Upcoming earnings on 2026-04-21 will focus on systems placements, consumable growth rates, and margin trajectory.

Final Thoughts

Short-term, ISRG stock trades below both its 50-day $493.85 and 200-day $507.15 averages, reflecting a pullback after strong multi-year gains. Medium-term upside rests on continued system adoption, consumable recurring revenue, and rollout of AI-enabled digital services that improve hospital outcomes. Meyka AI’s forecast model projects a yearly target $585.45, implying 27.00% upside from the current $460.99. Conversely, the monthly model near $438.35 implies a short-term downside around -4.91%, underlining near-term volatility. Our view: watch the April 21, 2026 earnings for confirmation of system orders and consumable growth. Use position sizing and stop rules if you trade into earnings, and note that Meyka AI is an AI-powered market analysis platform providing model-based forecasts. Forecasts are model-based projections and not guarantees.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.